Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients

Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients

Antibody-dependent cell-mediated cytotoxicity (ADCC) by NK cells is a key mechanism in anti-cancer therapies with monoclonal antibodies, including cetuximab (EGFR-targeting) and avelumab (PDL1-targeting). Fc gamma receptor IIIa (FcγRIIIa) polymorphisms impact ADCC, yet their clinical relevance in NK...

Full description

Saved in:

Bibliographic Details
Main Authors:	Phillip Schiele, Stefan Kolling, Stanislav Rosnev, Charlotte Junkuhn, Anna Luzie Walter, Jobst Christian von Einem, Sebastian Stintzing, Wenzel Schöning, Igor Maximilian Sauer, Dominik Paul Modest, Kathrin Heinrich, Lena Weiss, Volker Heinemann, Lars Bullinger, Marco Frentsch, Il-Kang Na
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Cells
Subjects:	antibody-dependent cell cytotoxicity cetuximab colorectal neoplasms flow cytometry single nucleotide polymorphism natural killer cells
Online Access:	https://www.mdpi.com/2073-4409/14/1/32
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides
by: Serkan Yazıcı, et al.
Published: (2015-01-01)

Persistent NK cell deficiency associated with pulmonary cryptococcosis
by: Martin Martinot, et al.
Published: (2025-01-01)

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
by: Jeng-Fu You, et al.
Published: (2025-02-01)

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
by: Shuxian Zhu, et al.
Published: (2025-01-01)

Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature
by: Prashant Mane, et al.
Published: (2024-04-01)

Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature
by: Prashant Mane, et al.
Published: (2023-07-01)

Changes in immune status of circulating NK cells in patients with latent tuberculosis infection
by: Shuang Qin, et al.
Published: (2024-08-01)

The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19
by: Clara Hernández-Blanco, et al.
Published: (2025-02-01)

Iron improves the antiviral activity of NK cells
by: Simone Schimmer, et al.
Published: (2025-01-01)

NK-92 cells activated by IL-2 inhibit the progression of endometriosis in vitro
by: Jun Yao, et al.
Published: (2024-12-01)

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study
by: Susanne Klein‐Scory, et al.
Published: (2025-02-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer
by: Rachel Pounds, et al.
Published: (2025-01-01)

Sinonasal NUT carcinoma: A case report and literature review
by: Quentin Josset, et al.
Published: (2024-06-01)

Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma
by: Juanyan Liao, et al.
Published: (2025-01-01)

STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
by: O. I. Kit, et al.
Published: (2019-09-01)

Effects of NK cell-related lncRNA on the immune microenvironment and molecular subtyping for pancreatic ductal adenocarcinoma
by: Jinze Li, et al.
Published: (2025-01-01)

<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
by: V. G. Subrakova, et al.
Published: (2020-03-01)

Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
by: Md Abdullah Al Kamran Khan, et al.
Published: (2025-01-01)

Development of Murine Hepatic NK Cells during Ontogeny: Comparison with Spleen NK Cells
by: Xian Wu, et al.
Published: (2012-01-01)

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients
by: Fang Wu, et al.
Published: (2025-01-01)

Construction and validation of a prognostic model for NK/T-cell lymphoma based on random survival forest algorithm
by: HUANG Zhen, et al.
Published: (2025-02-01)

EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer
by: Yongbin Zheng, et al.
Published: (2025-02-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01)

Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells
by: Jane Yu, et al.
Published: (2025-01-01)

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
by: Yaya Chu, et al.
Published: (2025-03-01)

Flow cytometric characterisation of acute leukaemia in adolescent and adult Ethiopians
by: Jemal Alemu, et al.
Published: (2025-01-01)

Oxaliplatin-Loaded Chitosan Nanoparticles Decorated with Cetuximab Single-Chain Variable Fragment for Human Colorectal Cancer Treatment
by: Khadijeh Falahzadeh, et al.
Published: (2024-09-01)

Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
by: Pui Yeng Lam, et al.
Published: (2025-01-01)

Survival and prognostic factors for primary lung extranodal NK/T-cell lymphoma: a retrospective study of data from China and the SEER database
by: Qiuyu Li, et al.
Published: (2025-01-01)

Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
by: Yuxiang Huang, et al.
Published: (2025-01-01)

The Role of NK Cells in Pig-to-Human Xenotransplantation
by: Gisella Puga Yung, et al.
Published: (2017-01-01)

NK-DC Crosstalk in Immunity to Microbial Infection
by: Rony Thomas, et al.
Published: (2016-01-01)

The Increased Ratio of Blood CD56bright NK to CD56dim NK Is a Distinguishing Feature of Primary Sjögren’s Syndrome
by: Bingxia Ming, et al.
Published: (2020-01-01)

NK Cell Subtypes as Regulators of Autoimmune Liver Disease
by: Guohui Jiao, et al.
Published: (2016-01-01)

Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes
by: Yan-Hua Wang, et al.
Published: (2024-01-01)

Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain
by: Ruth Alvarez Cabellos, et al.
Published: (2025-01-01)

Integration of single-cell and bulk RNA-sequencing data to construct and validate a signature based on NK cell marker genes to predict immunotherapy response and prognosis in colorectal cancer
by: Xiaoyu Qin, et al.
Published: (2025-02-01)

Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling
by: Bisha Ding, et al.
Published: (2025-02-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)